Radiopharm Theranostics Limited

RADX ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024
Assets
Cash & Equivalents $29.1M $18.6M
Accounts Receivable $10.4M $987.4K
Inventory — —
Total Current Assets $39.9M $22.8M
Property, Plant & Equipment — —
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $86.5M $72.0M
Liabilities
Accounts Payable $9.3M $10.9M
Total Current Liabilities $14.9M $17.6M
Long-Term Debt — —
Total Liabilities $43.6M $44.7M
Stockholders' Equity
Retained Earnings — —
Total Stockholders' Equity $42.9M $27.4M